Gland Pharma’s promoter sells 6% stake in company

20 Jun 2024 Evaluate

Fosun Pharma, one of the key promoters of Gland Pharma, has divested a substantial 6 per cent stake in the company through an open market transaction.

Chinese pharmaceutical giant Fosun Pharma, operating via its subsidiary Fosun Pharma Industrial Pte, executed the sale through a significant bulk deal on the BSE. Specifically, Fosun Pharma Industrial Pte relinquished 99 lakh shares, representing a 6 per cent stake in the Hyderabad-based Gland Pharma.

The shares were sold at an average price of Rs 1,771.81 each, culminating in a deal valued at Rs 1,754.09 crore. As a result of this transaction, Fosun Pharma's ownership in Gland Pharma has reduced from 57.86 per cent to 51.86 per cent. Meanwhile, UBS Principal Capital Asia acquired 8.25 lakh shares, resulting in a 0.5 per cent ownership in Gland Pharma, at an average purchase price of Rs 1,771.05 per share, translating to a total investment of Rs 146.11 crore.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1653.35 3.95 (0.24%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×